Patents by Inventor John Jessen Wright

John Jessen Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARYL SULFONAMIDES
    Publication number: 20120101097
    Abstract: The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating inflammatory and immune diseases.
    Type: Application
    Filed: March 10, 2011
    Publication date: April 26, 2012
    Inventors: Solomon Ungashe, John Jessen Wright, Andrew Pennell
  • ARYL SULFONAMIDES
    Publication number: 20110201610
    Abstract: The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating inflammatory and immune diseases.
    Type: Application
    Filed: March 10, 2011
    Publication date: August 18, 2011
    Inventors: Solomon Ungashe, John Jessen Wright, Andrew Pennell
  • Aryl sulfonamides
    Patent number: 7932252
    Abstract: The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating inflammatory and immune diseases.
    Type: Grant
    Filed: May 12, 2005
    Date of Patent: April 26, 2011
    Assignee: ChemoCentryx, Inc.
    Inventors: Solomon Ungashe, John Jessen Wright, Andrew Pennell
  • Substituted quinolones and methods of use
    Patent number: 7557213
    Abstract: Substituted quinolone compounds and compositions are provided along with methods for the use of those compounds in the treatment of diseases and disorders such as cancer.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: July 7, 2009
    Assignee: ChemoCentryx, Inc.
    Inventors: Anita Melikian, John Jessen Wright, Antoni Krasinski, Cheng Hu, Aaron Novack
  • Treatment of Asthma with Aryl Sulfonamides
    Publication number: 20080214672
    Abstract: The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating asthma.
    Type: Application
    Filed: December 18, 2007
    Publication date: September 4, 2008
    Inventor: John Jessen Wright
  • Aryl Sulfonamides
    Publication number: 20080161345
    Abstract: The present invention relates to compounds that modulate various chemokine receptors. These compounds are useful for treating inflammatory and immune diseases.
    Type: Application
    Filed: May 12, 2005
    Publication date: July 3, 2008
    Inventors: Solomon Ungashe, John Jessen Wright, Andrew Pennell
  • Aryl sulfonamides
    Patent number: 6939885
    Abstract: Compounds are provided that act as potent antagonists of the CCR9 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR9. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: September 6, 2005
    Assignee: Chemocentryx
    Inventors: Solomon Ungashe, Zheng Wei, John Jessen Wright, Andrew Pennell